Anti-RABV G Neutralizing Antibody (V3S-0522-YC3952) (CAT#: V3S-0522-YC3952)

Send Inquiry
  • fig1
    Figure 1 Anti-RABV G Monoclonal Antibody (V3S-0522-YC3952) in WB

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Rabies virus transmembrane glycoprotein G. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Rabies Virus (RABV)
Isotype IgG, κ

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application WB; ELISA; Neut
Application Notes The antibody is recommended for detection of RABV G by ELISA, Neut assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target RABV G
Alternative Name Rabies Virus; RABV; Rabies Virus transmembrane glycoprotein G; RABV G
Gene ID 1489856
UniProt P08667
Research Area Microbiology; Infectious Disease
Related Disease Rabies Virus infection

Tested Data

WB

Figure 1 Anti-RABV G Monoclonal Antibody (V3S-0522-YC3952) in WB

Western blot analysis of V3S-0522-YC3952 was performed by loading RABV G.
The incubation concentration of V3S-0522-YC3952 is 0.2 mg/mL.
The secondary antibody: HRP-anti-human IgG
Lane 1: Reduced antigen (0.1 μg)
Lane 2: Reduced antigen (0.3 μg)
Lane 3: Reduced antigen (0.6 μg)

Figure 1 Anti-RABV G Monoclonal Antibody (V3S-0522-YC3952) in WB

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry